Herceptin Funding This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Notice to Update Due Date for RFA-FD-17-006 "Developing Biomarkers for Trastuzumab-induced Cardiotoxicity"
Notice NOT-FD-17-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 7, 2017 Category: Research Source Type: funding

Developing Biomarkers for Trastuzumab-induced Cardiotoxicity (R30)
Funding Opportunity RFA-FD-17-006 from the NIH Guide for Grants and Contracts. This award is intended to provide support to conduct clinical studies at a clinical site with capability and patients samples to investigate potential biomarker (cMLC1) for trastuzumab-induced cardiotoxicity. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 22, 2017 Category: Research Source Type: funding